The device was returned to biosense webster inc.(bwi) for evaluation.Visual inspection and functionality test of the returned device were performed following bwi procedures.Visual inspection was performed, and a hole was observed on the pebax surface with reddish material inside.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.The damage on the pebax reported by the customer was confirmed.The potential cause of the damage on the pebax could be related to the usage of the device during procedure; however, this cannot be conclusively determined.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
It was reported that a patient underwent an atrial flutter right (r-afl) procedure with a thermocool® smart touch® sf bi-directional navigation catheter for which biosense webster¿s product analysis lab (pal) identified a hole in the pebax.Initially, it was reported that there was blood inside the lumen of the ablation catheter.It was was observed on pebax area of the catheter.It was unknown if the catheter pebax was physically damaged.The physician removed the catheter from the body for inspection.The catheter was replaced, and the issue was resolved, and the case continued.A replacement catheter was requested.No adverse patient consequence was reported.The issue with foreign material (blood) found was assessed as non mdr reportable.The potential risk that it could cause or contribute to a serious injury or death to the operator or patient was remote.The biosense webster, inc.Product analysis lab received the device for evaluation and per the evaluation completion on 19-mar-2024 there was a hole observed on the pebax surface with reddish material inside.The hole in the pebax was assessed as mdr reportable.The awareness date for this reportable lab finding was 19-mar-2024.
|